Rafael DepetrisLead of Structure Based Drug Design at Kadmon Corporation, LLC, USA
Rafael obtained his Ph.D. from NYU in 2008 working with Stevan Hubbard in the field of X-Ray crystallography, specifically focusing on the structural analysis of proteins that interact with the insulin receptor. His post-graduate work was done at Weill Cornell Medical College where he focused in the structural analysis of the HIV-1 Envelope proteins as well as of the HIV-1 neutralizing antibodies. Rafael went on to assume a position of a Senior Scientist at Pfizer CTI in New York, where he initiated his work focused on modeling of targets and therapeutic antibody candidates. He was also commanding the efforts for the humanization of the lead antibody candidates based on the modeling analyses. Rafael is continuing to explore structural features of biologics and their targets in his current position as a Principal Scientist at the Kadmon Corporation in NYC. At Kadmon he is combining his expertise in structural biology with in silico approaches to drive forward discovery projects. He has participated in many symposia, speaking about the interplay of structural analysis and computational tools.